warm autoimmune hemolytic anemia
Showing 1 - 25 of 4,369
Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
- Obexelimab
- Placebo
- (no location specified)
Mar 24, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2023
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 20, 2023
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Singapore (Ianalumab, Placebo)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- Ianalumab
- Placebo
-
Singapore, SingaporeNovartis Investigative Site
Jan 5, 2023
Anemia, Hemolytic, Autoimmune Trial (Nipocalimab)
Temporarily not available
- Warm Autoimmune Hemolytic Anemia
- (no location specified)
Nov 15, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (rilzabrutinib)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
-
Washington, District of Columbia
- +12 more
Oct 28, 2022
Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Riverside, CaliforniaClinical Study Site
Feb 2, 2022
Warm Autoimmune Hemolytic Anemia Trial in Worldwide (RVT-1401 680 mg/weekly, RVT-1401 340 mg/weekly)
Terminated
- Warm Autoimmune Hemolytic Anemia
- RVT-1401 680 mg/weekly
- RVT-1401 340 mg/weekly
-
Iowa City, Iowa
- +20 more
Jul 1, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial (HMPL-523(300mg PO QD), Placebo)
Not yet recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- HMPL-523(300mg PO QD)
- Placebo
- (no location specified)
Sep 7, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (Isatuximab SAR650984)
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- Isatuximab SAR650984
-
Los Angeles, California
- +8 more
Mar 16, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (parsaclisinib, )
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- parsaclisinib
- placebo
-
Los Angeles, California
- +52 more
Nov 15, 2022
Bullous Pemphigoid (BP), Cold Agglutinin Disease (CAD), Warm Autoimmune Hemolytic Anemia (WAIHA) Trial in Vienna (BIV009,
Completed
- Bullous Pemphigoid (BP)
- +3 more
- BIV009
- Placebo
-
Vienna, AustriaMedical University of Vienna
Apr 21, 2022
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in
Recruiting
- Autoimmune Hemolytic Anemia
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)
Enrolling by invitation
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
-
Los Angeles, California
- +36 more
Mar 2, 2022
Refractory/Relapsed Autoimmune Hemolytic Anemia Trial in Tianjin (Zanubrutinib)
Not yet recruiting
- Refractory/Relapsed Autoimmune Hemolytic Anemia
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Aug 27, 2023
Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)
Not yet recruiting
- Autoimmune Hemolytic Anemia
- Failure of Two Rounds of Treatment
-
Zhoukou, Henan, China
- +1 more
Jan 7, 2023
Warm Autoimmune Hemolytic Anemia Trial in Whittier (ALXN1830, Placebo)
Withdrawn
- Warm Autoimmune Hemolytic Anemia
- ALXN1830
- Placebo
-
Whittier, CaliforniaAlexion Study Site
Jul 9, 2020
Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease Trial in United States (APL-2)
Active, not recruiting
- Warm Autoimmune Hemolytic Anemia
- Cold Agglutinin Disease
-
Whittier, California
- +7 more
Nov 20, 2020
Circulating Cluster of Differentiation 4 Positive 28 Null T
Not yet recruiting
- Autoimmune Hemolytic Anemia
- (no location specified)
Jan 31, 2023
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in France (data collection)
Recruiting
- Immune Thrombocytopenia
- +2 more
- data collection
-
Amiens, France
- +8 more
Jul 7, 2023
Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)
Completed
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib 150 mg bid
-
Gilbert, Arizona
- +35 more
Jul 19, 2021
Autoimmune Hemolytic Anemia Trial in Worldwide (Parsaclisib)
Active, not recruiting
- Autoimmune Hemolytic Anemia
-
Washington, District of Columbia
- +11 more
Aug 26, 2022
Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a
Recruiting
- Autoimmune Hemolytic Anemia
- Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
- combination of a single dose anti-CD20 antibody and bortezomib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 12, 2021